These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18289027)

  • 1. Molecular insights and therapeutic targets in amyotrophic lateral sclerosis.
    Tripathi VB; Al-Chalabi A
    CNS Neurol Disord Drug Targets; 2008 Feb; 7(1):11-9. PubMed ID: 18289027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-modifying therapies in amyotrophic lateral sclerosis.
    Chiò A; Mazzini L; Mora G
    Neuropharmacology; 2020 May; 167():107986. PubMed ID: 32062193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Riluzole for the treatment of amyotrophic lateral sclerosis.
    Saitoh Y; Takahashi Y
    Neurodegener Dis Manag; 2020 Dec; 10(6):343-355. PubMed ID: 32847483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Riluzole, neuroprotection and amyotrophic lateral sclerosis.
    Cheah BC; Vucic S; Krishnan AV; Kiernan MC
    Curr Med Chem; 2010; 17(18):1942-199. PubMed ID: 20377511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyotrophic lateral sclerosis: clinical management and research update.
    Andrews J
    Curr Neurol Neurosci Rep; 2009 Jan; 9(1):59-68. PubMed ID: 19080755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
    Conde B; Winck JC; Azevedo LF
    Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of human corticospinal excitability by paired associative stimulation in patients with amyotrophic lateral sclerosis and effects of Riluzole.
    Ceccanti M; Onesti E; Rubino A; Cambieri C; Tartaglia G; Miscioscia A; Frasca V; Inghilleri M
    Brain Stimul; 2018; 11(4):775-781. PubMed ID: 29459142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Therapy of Drugs in Amyotrophic Lateral Sclerosis.
    Lu H; Le WD; Xie YY; Wang XP
    Curr Neuropharmacol; 2016; 14(4):314-21. PubMed ID: 26786249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roots to start research in amyotrophic lateral sclerosis: molecular pathways and novel therapeutics for future.
    Harikrishnareddy D; Misra S; Upadhyay S; Modi M; Medhi B
    Rev Neurosci; 2015; 26(2):161-81. PubMed ID: 25720096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed?
    Xu X; Shen D; Gao Y; Zhou Q; Ni Y; Meng H; Shi H; Le W; Chen S; Chen S
    Transl Neurodegener; 2021 Aug; 10(1):29. PubMed ID: 34372914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riluzole Exhibits No Therapeutic Efficacy on a Transgenic Rat model of Amyotrophic Lateral Sclerosis.
    Chen S; Liao Q; Lu K; Zhou J; Huang C; Bi F
    Curr Neurovasc Res; 2020; 17(3):275-285. PubMed ID: 32271694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amyotrophic lateral sclerosis].
    Veldink JH; Weikamp J; Schelhaas HJ; van den Berg LH
    Ned Tijdschr Tandheelkd; 2010; 117(7-8):380-2. PubMed ID: 20726497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three soccer playing friends with simultaneous amyotrophic lateral sclerosis.
    Wicks P; Ganesalingham J; Collin C; Prevett M; Leigh NP; Al-Chalabi A
    Amyotroph Lateral Scler; 2007 Jun; 8(3):177-9. PubMed ID: 17538780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment of ALS.
    Münch C; Ludolph AC
    Neurol Neurochir Pol; 2001; 35(1 Suppl):41-50. PubMed ID: 11732279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
    Ludolph AC; Schuster J; Dorst J; Dupuis L; Dreyhaupt J; Weishaupt JH; Kassubek J; Weiland U; Petri S; Meyer T; Grosskreutz J; Schrank B; Boentert M; Emmer A; Hermann A; Zeller D; Prudlo J; Winkler AS; Grehl T; Heneka MT; Wollebæk Johannesen S; Göricke B;
    Lancet Neurol; 2018 Aug; 17(8):681-688. PubMed ID: 29934198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amyotrophic lateral sclerosis. Current clinical trials and underlying pathomechanisms].
    Kollewe K; Dengler R; Petri S
    Nervenarzt; 2008 Jun; 79(6):653-61. PubMed ID: 18210046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium dysregulation in amyotrophic lateral sclerosis.
    Grosskreutz J; Van Den Bosch L; Keller BU
    Cell Calcium; 2010 Feb; 47(2):165-74. PubMed ID: 20116097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical diagnosis and management of amyotrophic lateral sclerosis.
    Hardiman O; van den Berg LH; Kiernan MC
    Nat Rev Neurol; 2011 Oct; 7(11):639-49. PubMed ID: 21989247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyotrophic Lateral Sclerosis: Autoimmune Pathogenic Mechanisms, Clinical Features, and Therapeutic Perspectives.
    Ralli M; Lambiase A; Artico M; de Vincentiis M; Greco A
    Isr Med Assoc J; 2019 Jul; 21(7):438-443. PubMed ID: 31507117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs.
    Goyal NA; Mozaffar T
    Expert Opin Investig Drugs; 2014 Nov; 23(11):1541-51. PubMed ID: 24965719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.